Basal body temperature charting can tell you that ovulation happened - after the fact (de Mouzon et al., 1984). LH strips can tell you a surge occurred - which may or may not result in ovulation. A timed hormone panel can tell you whether the hormonal infrastructure for fertility actually performed. Used together, they can remove almost all ambiguity from a single cycle.
Fertility awareness methods have been around for a century. What's changed is the ability to pair behavioural data - waking temperature, LH strips, cervical mucus observations - with a blood panel timed to the same cycle. The combination is what closes the loop.
What each tool can actually tell you
Basal body temperature (BBT)
After ovulation, progesterone can raise your resting body temperature by 0.2–0.5°C. This is the sustained thermal shift you're looking for on a BBT chart - a plateau that can hold for 12–14 days until your period. A sustained BBT rise may mean ovulation happened. It doesn't confirm when, doesn't confirm adequate progesterone, and can be disrupted by illness, alcohol, or inconsistent wake times.
LH strips
A positive LH test may mean a surge - which can come 24–36 hours before ovulation (Erden et al., 2022). But an LH surge doesn't guarantee ovulation follows. Luteinised unruptured follicle syndrome (LUF) can produce a surge without egg release, which may be more common in women with endometriosis (Kaya et al., 1999). LH strips are excellent for timing intercourse or insemination; they can't confirm ovulation.
The hormone panel
Blood can support what the other tools can only suggest. Progesterone above 10 ng/mL at day 21 (or 7 days post-LH surge) may point to ovulation and adequate corpus luteum function (Jordan et al., 1994). Estradiol in the luteal phase can characterise the estrogen environment. Together they can give you the hormonal reality behind the behavioural chart.
The two draws worth knowing
Day 3 draw (follicular baseline)
- FSH - ovarian reserve signal; elevated FSH (>10 IU/L) may suggest diminished reserve (Steiner et al., 2017).
- LH - baseline LH; can be elevated at baseline in PCOS (Blank et al., 2006).
- Estradiol - elevated day-3 estradiol (>80 pg/mL) can falsely suppress FSH, masking poor reserve.
- AMH - cycle-independent; can be drawn any day but commonly batched here (Gracia et al., 2018).
Day 21 draw (7 days post-ovulation)
- Progesterone - can help point to ovulation. >10 ng/mL: may mean strong ovulation. 3–10 ng/mL: may mean a weak luteal phase (Jordan et al., 1994). <3 ng/mL: may mean anovulation.
- Estradiol - in ratio with progesterone; high estradiol relative to low progesterone may be the estrogen dominance pattern.
If your cycle isn't 28 days
The day 21 draw should be 7 days after your confirmed LH surge or BBT thermal shift - not literally cycle day 21. In a 35-day cycle, mid-luteal may be day 28. Timing from ovulation, not from period start, is what can make the number interpretable.
Building a picture over time
A single cycle snapshot is informative. Two cycles give you reproducibility. Three give you a pattern. The most common finding across multiple cycles may not be dramatic - it may be mild progesterone insufficiency that's consistent, cycle after cycle, which can explain subtler symptoms: PMS that builds across the luteal phase, light sleep the week before menstruation, or a sense of emotional fragility that tracks perfectly with the chart.
Paired data makes the conversation with a clinician much more productive. Instead of 'my cycles feel off,' you arrive with: 'My LH surge is on day 16, BBT rises on day 17, but day-21 progesterone has been 6–7 ng/mL for three cycles.' That may be a clinical finding. That gets taken seriously.
References
- de Mouzon, J., et al. (1984). Time relationships between basal body temperature and ovulation or plasma progestins. Fertility and Sterility, 41(2), 254-259. PMID 6421622
- Erden, M., et al. (2022). The LH surge and ovulation re-visited: a systematic review and meta-analysis and implications for true natural cycle frozen thawed embryo transfer. Human Reproduction Update, 28(5), 717-732. PMID 35258085
- Kaya, H., et al. (1999). Effect of ovarian involvement on the frequency of luteinized unruptured follicle in endometriosis. Gynecologic and Obstetric Investigation, 48(2), 123-126. PMID 10461004
- Jordan, J., et al. (1994). Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertility and Sterility, 62(1), 54-62. PMID 8005304
- Steiner, A. Z., et al. (2017). Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA, 318(14), 1367-1376. PMID 29049585
- Blank, S. K., et al. (2006). The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Human Reproduction Update, 12(4), 351-361. PMID 16670102
- Gracia, C. R., et al. (2018). Multi-center clinical evaluation of the Access AMH assay to determine AMH levels in reproductive age women during normal menstrual cycles. Journal of Assisted Reproduction and Genetics, 35(5), 777-783. PMID 29536384
